AP report on FDA warning over misleading promotional claims for ANKTIVA TV ad and podcast.
NANT Cancer Vaccine / Cancer BioShield
NANT Cancer Vaccine / Cancer BioShield is a investigational cancer vaccine and immune-platform concept associated with combination immunotherapy, tumor antigen presentation, immune activation, and personalized or platform-based cancer treatment strategies. In cancer care, it should be evaluated by evidence level, intended use, safety, interactions, and whether it is being used as conventional treatment, supportive care, an experimental adjunct.
Press release/source on NANT Cancer Vaccine patent and trials.